Comparison of Two Formulations of Cyclosporin A in the Treatment of Severe Atopic Dermatitis

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Dermatology

• Publication date

  1999-02-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000018065PMID 10026403
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Atopic dermatitis: immunobiology and treatment with immune modulators.

  1997cited by this paper
• Atopic dermatitis: immunobiology and treatment with immune modulators.

  1997cited by this paper
• Comparison of cyclosporin A pharmacokinetics of a new microemulsion formulation and standard oral preparation in patients with psoriasis

  1997cited by this paper
• A new microemulsion formulation of cyclosporin (Neoral) is effective in the treatment of cyclosporin‐resistant dermatoses

  1996cited by this paper
• Comparison of the steady state pharmacokinetics of two formulations of cyclosporin in patients with atopic dermatitis *

  1996cited by this paper
• Levels of soluble ICAM‐1 in atopic dermatitis A new marker for monitoring the clinical activity?

  1995cited by this paper
• Efficacy and Pharmacokinetics of Two Formulations of Cyclosporine A in Patients with Psoriasis

  1995cited by this paper
• Differential cytokine profiles in peripheral blood lymphocyte supernatants and skin biopsies from patients with different forms of atopic dermatitis, psoriasis and normal individuals.

  1994cited by this paper
• Rationale for the development of Sandimmune Neoral.

  1994cited by this paper
• Maintenance treatment with cyclosporin in atopic eczema

  1994cited by this paper
• Can cyclosporin A induce permanent remission of atopic dermatitis?

  1993cited by this paper
• Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis.

  1992cited by this paper
• Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis.

  1991cited by this paper
• Renal function and blood pressure in psoriatic patients treated with cyclosporin A

  1990cited by this paper
• Evaluation and relevance of atopic basic and minor features in patients with atopic dermatitis and in the general population.

  1989cited by this paper
• Elevated levels of interleukin 2 receptor in sera of patients with atopic dermatitis and psoriasis

  1988cited by this paper
• Diagnostic Features of Atopic Dermatitis

  1980cited by this paper

• Ultraflexible lipid vesicles loaded with cyanocobalamin or cyclosporin A downregulate acute and chronic immuno-inflammatory skin states.

  2025cites this paper
• Immunosuppressive therapy for atopic dermatitis

  2025cites this paper
• A systematic review investigating the proportion of clinical images shared in prospective randomized controlled trials involving patients with atopic dermatitis and systemic pharmacotherapy

  2024cites this paper
• Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations.

  2023cites this paper
• Clinical phenotypes of adult atopic dermatitis and related therapies

  2022cites this paper
• Atopic dermatitis. Clinical guidelines

  2021cites this paper
• Update “Systemic treatment of atopic dermatitis” of the S2k‐guideline on atopic dermatitis

  2021cites this paper
• Aktualisierung„ Systemtherapie bei Neurodermitis“ zur S2k‐Leitlinie Neurodermitis

  2021cites this paper
• Systemic treatments in the management of atopic dermatitis: A systematic review and meta‐analysis

  2020cites this paper
• Inclusion of Older Adults in Randomized Clinical Trials for Systemic Medications for Atopic Dermatitis: A Systematic Review.

  2020cites this paper
• Monitoring trough levels in cyclosporine for atopic dermatitis: A systematic review

  2019cites this paper
• Relative efficacy of systemic treatments for atopic dermatitis.

  2019cites this paper
• Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I

  2018cites this paper
• Systemic treatments for eczema: a network meta-analysis.

  2018cites this paper
• Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II

  2018cites this paper
• Oral Systemic Agents in Pediatric Dermatology

  2018cites this paper
• Atopic dermatitis: phototherapy and systemic therapy

  2017cites this paper
• Prescription Treatment Options.

  2017cites this paper
• Review of Systemic Treatment Options for Adult Atopic Dermatitis

  2017cites this paper
• 2 Topical Prescription Agents 10 . 2 . 1 Topical Corticosteroids

  2017cites this paper
• Liječenje atopijskog dermatitisa

  2017cites this paper
• Management of Atopic Dermatitis

  2017influential citation
• [Not Available].

  2016cites this paper
• Special Therapeutic Options and Substances in the Treatment of Atopic Eczema

  2016cites this paper
• Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis]

  2016cites this paper
• IgE responses to exogenous and endogenous allergens in atopic dermatitis patients under long‐term systemic cyclosporine A treatment

  2015cites this paper
• Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part II): Systemic Treatment

  2015cites this paper
• Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.

  2014cites this paper
• Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.

  2014cites this paper
• Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.

  2014cites this paper
• Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches.

  2014cites this paper
• Treatment of Severe Atopic Dermatitis with Cyclosporine: A Review of Eight Patients

  2013cites this paper
• Guidelines for treatment of atopic eczema (atopic dermatitis) Part I

  2012cites this paper
• Recent Advances in Treatment Strategies for Atopic Dermatitis

  2012cites this paper
• Guidelines for treatment of atopic eczema (atopic dermatitis) Part II

  2012cites this paper
• Prednisolone vs. ciclosporin for severe adult eczema. An investigator‐initiated double‐blind placebo‐controlled multicentre trial

  2010cites this paper
• Update on the Management of Atopic Dermatitis/Eczema

  2009cites this paper
• Neurodermitis S2‐Leitlinie

  2009cites this paper
• [Atopic dermatitis: S2 guidelines].

  2009cites this paper
• Cyclosporin in the treatment of patients with atopic eczema – a systematic review and meta‐analysis

  2007cites this paper
• Effect of Bifidobacteriuminfantis on Interferon- γ- Induced Keratinocyte Apoptosis: A Potential Therapeutic Approach to Skin Immune Abnormalities

  2006cites this paper
• Quelle prise en charge pour les dermatites atopiques sévères et chroniques de l'enfant ?

  2005cites this paper
• Quelle prise en charge pour les dermatites atopiques sévères et chroniques de l’enfant ?

  2005cites this paper
• [Current treatment of atopic dermatitis in adults].

  2003cites this paper
• Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring?

  2003cites this paper
• Reliability testing of the Six Area, Six Sign Atopic Dermatitis severity score

  2002cites this paper
• Refractory atopic dermatitis treated with low dose cyclosporin.

  2002cites this paper
• Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis.

  2001cites this paper
• Pharmacologic alternatives for severe atopic dermatitis

  2001cites this paper
• Dermatologic and ocular diseases Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis

  2001cites this paper
• Effect of Low-Dose Cyclosporin A Microemulsion on Disease Severity, Interleukin-6, Interleukin-8 and Tumor Necrosis Factor Alpha Production in Severe Pediatric Atopic Dermatitis

  2001cites this paper
• Soluble E‐selectin correlates with disease activity in cyclosporin A‐treated patients with atopic dermatitis

  1999cites this paper
• Perspectivas actuais na dermatite atópica: da imunopatologia à terapêutica TEMA DE ACTUALIZAÇÃO

  year unknowncites this paper
• Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE

  year unknowncites this paper